MSCI, Clinical Investigation, Washington University in St. Louis, 2022
MD, Multiple Sclerosis Fellowship, Washington University in St. Louis, 2021
MD, Neurology Residency, Washington University in St. Louis, 2019
MD, Medicine, Florida Atlantic University, 2015
BS, Biology, University of Florida, 2010
BA, Economics, University of Florida, 2010
Awards/Honors
Sylvia Lawry Physician Fellowship (National MS Society - 2020)
Abdullah M. Nassief Award (Washington University in St. Louis - 2018)
Irwin Levy Resident Teaching Award (Washington University in St. Louis - 2018)
Gold Humanism Honor Society (Gold Humanism Honor Society - 2014)
Recent Publications
Samara A, Xiang B, Judge B, Ciotti JR, Yablonskiy D, Cross AH, Brier MR. Increased periventricular thalamic damage gradient in multiple sclerosis detected by quantitative gradient echo MRI.Mult Scler Relat Disord. 90:105834, 2024.
Stefan KA, Ciotti JR. MOG antibody disease: nuances in presentation, diagnosis, and management.Current Neurology and Neuroscience Reports. doi: 10.1007/s11910-024-01344-z, 2024.
Mayfield JD, Murtagh R, Ciotti JR, Robertson DS, El Naqa I. Time-dependent deep learning prediction of multiple sclerosis disability.Journal of Imaging Informatics in Medicine. doi: 10.1007/s10278-024-01031-y, 2024.
Kolli A, Ciotti J. Updates in Bruton's tyrosine kinase inhibition for multiple sclerosis.Practical Neurology. 22(2) , 2023.
Brier MR, Xiang B, Ciotti JR, Chahin S, Wu GF, Naismith RT, Yablonskiy D, Cross AH. Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD.Multiple Sclerosis and Related Disorders. 73: 104659, 2023.
Lambe J, McGinley MP, Moss BP, Mao-Draayer Y, Kassa R, Ciotti JR, Mariotto S, Kunchok A. Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series.Journal of Neuroimmunology. 370: 577933, 2022.
Ciotti JR, Perantie DC, Moss BP, Fitzgerald KC, Cohen JA, Mowry EM, Naismith RT, Chahin S. Perspectives and experiences with COVID-19 vaccines in people with MS.Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8(1) : 20552173221085242, 2022.
Ciotti JR, Eby NS, Brier MR, Wu GF, Chahin S, Cross AH, Naismith RT. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica.Multiple Sclerosis Journal. 28(1) : 49-60, 2022.
Ciotti JR, Eby NS, Wu GF, Naismith RT, Chahin S, Cross AH. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica.Multiple Sclerosis and Related Disorders. 45: 102399, 2020.
Ciotti JR, Valtcheva MV, Cross AH. Effects of MS disease-modifying therapies on responses to vaccinations: A review.Multiple Sclerosis and Related Disorders. 45: 102439, 2020.
Ciotti JR, Grebenciucova E, Moss BP, Newsome SD. Multiple Sclerosis Disease-Modifying Therapies in the COVID-19 Era.Annals of Neurology. 88(6) : 1062-1064, 2020.
Ciotti JR, Sanders N, Salter A, Berger JR, Cross AH, Chahin S. Clinical instrument to retrospectively capture levels of EDSS.Multiple Sclerosis and Related Disorders. 39: 101884, 2019.
Ciotti JR, Cross AH. Disease-Modifying Treatment in Progressive Multiple Sclerosis.Current Treatment Options in Neurology. 20(5) : 12, 2018.
